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DISCUSSION
Dr Thomas O’Donnell (Boston, Mass). Your interesting pre-
sentation raises several questions. First of all, who performed the
original surgery? Were the procedures done on your unit, and, if
not, did you have access to the case notes in order to determine the
experience level of the initial surgeon registrar, junior registrar, or
consultant? Since your presentation suggests that many of the
recurrences may be due to technical causes, the level of experience
of the operating surgeon would be an important factor in avoiding
technical causes of recurrence.
My second question is directed toward the use of preoperative
diagnostic duplex studies. In the UK and Ireland, I gather, routine
duplex exams of patients prior to varicose vein surgery is not the
norm. By contrast, in the United States, for several reasons, par-
ticularly due to insurance requirements for documentation of
reflux, patients undergo preop duplex studies. As a result, the
surgeon might be aware of anatomical abnormalities such as a
duplicated great saphenous, which could lead to “recurrence.”
Finally, most of us in the United States have shifted to an
endovenous ablation technique for saphenous reflux, so that your
series on recurrences following the “open” technique may be an
interesting benchmark against which to compare the causes of
recurrence following endovenous ablation. In addition, we have
used endovenous ablation to manage reoccurrence after “open”
surgery.
Thank you for your stimulating presentation.
Dr Feeley. The primary operations were carried out in a large
number of institutions by a large number of surgeons. No, it wasn’t
possible to get these data. The results are totally in keeping with all
other reports, surgical series, of recurrent varicose veins and their
causes.
I think the data here are not of historical interest; I think they
are extremely relevant and important in relation to the newer
treatment modalities. The finding that 20% of patients had a stump
with tributaries as the only source of reflux is extremely important.
Dr Peter Gloviczki (Rochester, Minn). I believe accessory
saphenous veins missed during surgery are more frequently the
cause of recurrence than neovascularization. However, we cannot
completely neglect neovascularization because there is quite a bit
of evidence in the literature that neovascularization, at least in
some studies—and I’m referring to Professor Van Rij’s study in the
Journal of Vascular Surgery published 2 years ago—is the most
frequent cause of recurrence. It is possible that neovascularization
is the most frequent cause, after flush high ligation of the saphe-
nous vein and accessory saphenous veins, as the most frequent
cause after low ligation.
In Van Rij’s paper, a histologic evaluation was performed to
distinguish between residual normal venous tributaries and imma-
ture vessels of neovascularization. So I’m wondering if you have
done any histologic study to provide evidence that those vessels
that caused recurrence were indeed residual mature vessels and not
neovascularizations.
Dr Feeley. Yes, certainly, if one is to read the literature, the
importance of neovascularization is very evident. However, the
vast majority of these studies are based on imaging only. There is
no surgical corroboration of the duplex findings. I would suggest
to you that duplex findings are images and their interpretation is
what’s important. I suggest that these series of duplex neovascu-
larizations are in fact GSV stump tributaries.
The second question was histology. Yes, I agree that this
would be very nice, and it has been done by others, including
Jonathan Earnshaw, and they have shown neovascularization.
First, I didn’t do it, not because I’m lazy, but I may be a
coward. I think excising tissue from the groin of a patient out of
curiosity with the possible result of limb edema is not justifiable. I
am not denying that new vessels grow in scar and healing tissue;
I’m not arguing with that at all. There is no doubt that it does
happen. What I am saying is that it is not an important factor in the
etiology of recurrent varicose veins.
DrCharles Brantigan (Denver, Colo). I would like to put you
on the spot and ask how your work relates to endovenous ablation
of varicose veins.
The endovenous ablation techniques are not able to deal with
those branches that you’ve described at the saphenofemoral junc-
tion, and, in fact, there have been publications suggesting that it’s
best to leave those branches intact.
How does the work that you’re reporting today relate to the
new techniques in endovenous therapy? On the basis of your
data, what do you expect the long-term results of these proce-
dures to be?
Dr Feeley. Well, first, there have been reports, even at this
early stage, of neovascularization following the endovenous abla-
tion techniques. The retention of the junctional branches, as we
call them, is believed to be important. I have just shown you that
these junctional branches with the retained stump, in this study,
were present in 37.6% of recurrences and were the only source of
reflux in 20%.
I should point out that the debate really is whether these
tributaries to which I refer are in fact newly developed vessels, what
you call neovascularization, or whether they are, in fact, retained
missed tributaries. These tributaries were identical to those which
I saw and described in an anatomic study I did in parallel with this,
in which I dissected 2089 groins, and furthermore over 33% had
what I call junctional branches—in other words, joined at the
saphenofemoral junction line or deep to the fascia.
Dr Harry Schanzer (New York, NY). I enjoyed your paper
very much. It is very provocative, when considering the new
endovenous techniques.
My question is directed to what just was discussed. In the
endovenous techniques, one deliberately does the equivalent of a
low saphenous ligation, leaving the most proximal tributaries
subjected to reflux from the incompetent saphenofemoral valve.
The question is, how long it is necessary to wait to see if this
potential reflux produces recurrences? In your study, what was the
time frame between surgery and the onset of recurrence?
Dr Feeley. Yes, I agree, we have to wait for a number of years
before we find out the real value of endovenous therapies.
It would be interesting to know, and unfortunately I don’t
know the answer to your question. They were over a wide range of
time and, indeed, most patients can’t remember exactly when they
had their surgery.
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